FARADAY FUTURE INTELLIGENT ELECTRIC INC. (FFAI)
CIK 1805521 · all EDGAR filings →
Same rating bands the category standard uses, but free, with the formula on the chip and the gaps in the data said out loud.
Shares outstanding over time
Latest: 29.5M shares as of Aug 13, 2021 (10-Q).
Cash runway
Going-concern warning
auditor flagged substantial doubt
The company itself flagged going-concern doubt in a filing.
Full breakdown: cash runway tool
Warrants
| Tranche | Warrants | Exercise price | Term | Notes |
|---|---|---|---|---|
| A2025 Placement Agent Warrants | 1.1M | $2.47 | — | — |
| Other Warrants | 72,004 | $5.82 | — | — |
| A2024 Pre Funded Warrants | 51,199 | $0.05 | — | — |
| A2025 March Unsecured SPA Warrants | 46,659 | $219.6 | — | — |
| Ares Warrants | 43,963 | $152.42 | — | — |
| A2025 July Unsecured SPA Warrants | 27,621 | $157.2 | — | — |
| A2024 Unsecured SPA Warrants | 19,171 | $157.2 | — | — |
| A2024 Placement Agent Warrants | 16,019 | $7.8 | — | — |
| Junior SPA Warrants | 3,499 | $152.61 | — | — |
| Junior Secured SPA Warrants | 3,499 | $174 | — | — |
| Preferred Warrants | 107 | $1270.25 | — | — |
| SPA Warrants | 53 | $32.01 | — | — |
Tranches exactly as the company dimensioned them in its 10-Q filed Aug 13, 2026 →. Groupings can overlap (a “Series E and F” row is not additive with a “Series E” row), so do not sum this column. A tranche the filer did not tag is absent here, not absent from the cap table. DOWN-ROUND = the filer tagged price-protection accounting scoped to that tranche.
Warrants outstanding: 23.0M underlying shares, as reported Jun 30, 2021 (10-Q).
Reported exercise price: $219.6 (aggregate figure as tagged; individual tranches vary).
Rough fully diluted estimate: 52.5M = 29.5M O/S + 23.0M warrant shares. An estimate, not a filing figure: it ignores converts, options and RSUs, and the two inputs carry different as-of dates.
Convertible notes
| Note | Principal | Carrying | Conv. price | Rate | If converted |
|---|---|---|---|---|---|
| 2025 July Unsecured SPA Notes | $83.5M | $14.7M | $252 | 10%-18% | ~331,349 sh |
| 2025 March Unsecured SPA Notes | $41.0M | $8.5M | $183 | 10%-18% | ~224,044 sh |
| Secured Streeterville Notes | $30.0M | $45.8M | $9.05 | 3.5%-18% | ~3.3M sh |
| May 2026 Convertible Notes | $25.0M | $27.0M | $58.23 | 8%-18% | ~429,332 sh |
| 2023 Unsecured SPA Notes | not tagged | $4.5M | $174 | 10%-15% | — |
| 2025 Convertible Note AIXC | $300,000 | — | $2.25 | — | ~133,333 sh |
| 2024 Unsecured SPA Notes | not tagged | $33,000 | $32.01 | 10% | — |
| Secured SPA Notes | not tagged | — | $174 | 3.5%-15% | — |
| Junior Secured SPA Notes | not tagged | — | $174 | 10% | — |
If every note above converted at its tagged price: ~4.4M new shares on 29.5M currently outstanding. An estimate from principal ÷ conversion price, with inputs carrying different as-of dates; make-whole adjustments, capped calls and partial repurchases are not modeled.
Notes exactly as the company dimensioned them in its 10-Q filed Aug 13, 2026 →. Principal is face amount as tagged, not what remains after repurchases unless the filer updated the tag. A note the filer did not dimension is absent here, not absent from the balance sheet; the exhibits stay the ground truth.
Fully diluted build-up
Shares outstanding plus every potential-share instrument the filer tagged in XBRL, each at its own as-of date. An estimate assembled from filed figures, not a filing figure itself.
| Shares outstanding | 29.5M | Aug 13, 2021 |
| + A2025 Placement Agent Warrants (if exercised) | 1.1M | Jun 30, 2026 |
| + Other Warrants (if exercised) | 72,004 | Jun 30, 2026 |
| + A2024 Pre Funded Warrants (if exercised) | 51,199 | Jun 30, 2026 |
| + A2025 March Unsecured SPA Warrants (if exercised) | 46,659 | Jun 30, 2026 |
| + Ares Warrants (if exercised) | 43,963 | Jun 30, 2026 |
| + A2025 July Unsecured SPA Warrants (if exercised) | 27,621 | Jun 30, 2026 |
| + A2024 Unsecured SPA Warrants (if exercised) | 19,171 | Jun 30, 2026 |
| + A2024 Placement Agent Warrants (if exercised) | 16,019 | Jun 30, 2026 |
| + Junior SPA Warrants (if exercised) | 3,499 | Jun 30, 2026 |
| + Junior Secured SPA Warrants (if exercised) | 3,499 | Dec 31, 2025 |
| + Preferred Warrants (if exercised) | 107 | Jun 30, 2026 |
| + SPA Warrants (if exercised) | 53 | Jun 30, 2026 |
| + 2025 July Unsecured SPA Notes (if fully converted) | 331,349 | Aug 21, 2025 |
| + 2025 March Unsecured SPA Notes (if fully converted) | 224,044 | Mar 21, 2025 |
| + Secured Streeterville Notes (if fully converted) | 3.3M | Jun 30, 2026 |
| + May 2026 Convertible Notes (if fully converted) | 429,332 | May 15, 2026 |
| + 2025 Convertible Note AIXC (if fully converted) | 133,333 | Apr 28, 2025 |
| Fully diluted estimate | 35.3M | +19.7% vs O/S |
Still excluded, because the filer does not tag them in countable form: employee options and RSUs, any instrument living only in exhibit prose, and instruments above missing a share count. Inputs carry different as-of dates, shown per row. Each figure traces to the tranche and note tables above and their cited filings.
Registrations and offerings
Registered offering capacity on live registrations: $320.8Mfrom the structured fee exhibits; registered is not remaining, takedowns are not subtracted
Last 12 months: 7 executed · 6 registered.
Full history and shelf status: offering checker · S-3 shelf checker
Source: SEC EDGAR XBRL company facts and filing metadata, fetched live and cached briefly. Share counts are cover-page figures with their form named. Warrant tranches and convertible notes come from the dimensioned facts in the latest 10-Q/10-K instance document, exactly as the company tagged them; untagged tranches and notes are absent, not disproven. Nothing on this page is manually verified and nothing is behind a login: what free data supports is shown, what it cannot support is stated. Not investment advice.
Keep going: float checker · offering calendar · short-squeeze screener · full FFAI workspace